About: Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1994 (uk) im Juni 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1994 (ast) scientific article published on 01 June 1994 (en)
publication date	wds:Q72432218-A031EE67-20F2-4D8D-82EF-024E45C4A846
publication date	1994-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72432218-78AA1F7E-0508-4AD4-9805-BA1026A34A1E
language of work or name	English
cites work	wds:Q72432218-2C57619B-A46D-451C-89DB-CC561738410F wds:Q72432218-6B0D2872-0D9E-431F-8428-35A340C7C720 wds:Q72432218-822552B7-538A-4D19-8DDE-9FA3733203C9 wds:Q72432218-E70C285B-940A-4F9B-9F32-D09C2F4BD7B4
cites work	Severe Psoriasis – Oral Therapy with a New Retinoid Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis Fumaric acid monoethylester: Effect on DNA-synthesis and preliminary findings in experimental studies in animals (author's transl)
author name string	wds:Q72432218-17BDED56-0855-4BC5-90E3-AD4E876067D9 wds:Q72432218-2FC6B7E2-AE91-4F04-8F2D-E02EBC4FA2F3 wds:Q72432218-3731F7ED-B1FB-4C18-960A-669D3A97279E wds:Q72432218-8FF7823F-D86B-4371-B1BF-1DA7155CDDF4 wds:Q72432218-AB184F63-86C8-4AEE-91E4-7927AF42A2B0 wds:Q72432218-B4669730-1BA9-4455-BEF9-481F5D75C139 wds:Q72432218-BF34FB50-D51A-42EE-88BF-997DC46EF1C9 wds:Q72432218-C827D999-6A7F-4EAE-84D9-90C53B32BE44 wds:Q72432218-CB6B8495-9417-4D74-82F5-4B2A5C18E4D5 wds:Q72432218-CFDF03CC-919D-4352-8947-8BEA2770B085
author name string	K Hoffmann T Horn G Lutz P J Frosch S W Wassilew H W Kreysel P Ruppert U Matthes F Pawlak P J Altmeyer
rdfs:label	Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (en) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (nl)
skos:prefLabel	Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (en) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (nl)
name	Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (en) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (nl)
title	wds:Q72432218-7A567DBB-27B7-4A69-B775-C2174B966BF1
title	Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients (en)
page(s)	wds:Q72432218-260757CB-9C54-45FE-8537-7AC95E457111
page(s)	977-981
instance of	wds:Q72432218-25D9C4B6-7168-4BCE-8E5F-0D8BD9969021
instance of	scholarly article
PubMed ID	wds:Q72432218-80ACE142-DA20-4949-BBE5-DEEF2AEC40A4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8188891
PubMed ID	8188891
published in	wds:Q72432218-5FB6B5AE-AF45-4502-B539-7EAA809786E0
published in	Journal of the American Academy of Dermatology
issue	wds:Q72432218-3481E657-F3DE-458C-AFC0-8FF72AA1F14B
volume	wds:Q72432218-D1B77EBE-24EF-4B50-98C4-157841891E94
issue	6
volume	30
DOI	wds:Q72432218-7383FB71-E1FF-4E4E-B2DB-0887E917E780
DOI	http://dx.doi.org/10.1016/S0190-9622(94)70121-0
DOI	10.1016/S0190-9622(94)70121-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72432218
is cites work of	Psoriasis: emerging therapeutic strategies Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach Fumaric Acid and its esters: an emerging treatment for multiple sclerosis Pharmacology and Clinical Drug Candidates in Redox Medicine Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation Fumaric acid esters in the treatment of psoriasis: an Italian experience German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Pharmacokinetics of oral fumarates in healthy subjects. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy Fumaric acid production by fermentation Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? Antioxidants in Translational Medicine Redox-based therapeutics in neurodegenerative disease Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview In vitro pharmacokinetics of anti-psoriatic fumaric acid esters Fumaric acid and its esters in the treatment of multiple sclerosis: studies and effects Fumaric acid esters in dermatology. Methyl Fumarate-Derived Iron Carbonyl Complexes (FumET-CORMs) as Powerful Anti-inflammatory Agents. Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression. Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data. Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge. Malassezia and Parkinson's Disease Evaluating changes in structure and cytotoxicity during in vitro degradation of three-dimensional printed scaffolds Psoriasis Pathogenesis and Treatment

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software